A Study to Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing bictégravir, Emtricitabine and ténofovir alafénamide
Clinical trial NCT05222945 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05222945
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-01
- Primary completion
- 2025-10-30
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.